{"id":39930,"date":"2019-04-18T20:31:00","date_gmt":"2019-04-18T18:31:00","guid":{"rendered":"https:\/\/www.transgene.com\/?p=39930"},"modified":"2026-01-05T20:43:04","modified_gmt":"2026-01-05T19:43:04","slug":"the-efficacy-and-safety-of-tipapkinogen-sovacivec-tg4001-therapeutic-hpv-vaccine-in-cervical-intraepithelial-neoplasia-grades-2-and-3-randomized-controlled-phase-ii-trial-with-2-5-years-of-follow-u","status":"publish","type":"post","link":"https:\/\/www.transgene.com\/fr\/the-efficacy-and-safety-of-tipapkinogen-sovacivec-tg4001-therapeutic-hpv-vaccine-in-cervical-intraepithelial-neoplasia-grades-2-and-3-randomized-controlled-phase-ii-trial-with-2-5-years-of-follow-u\/","title":{"rendered":"The efficacy and safety of Tipapkinogen Sovacivec (TG4001) therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-up"},"content":{"rendered":"<p>Diane. M. Harper, et al.<br \/>Gynecologic Oncology, April 2019 &#8211; <a href=\"https:\/\/doi.org\/10.1016\/j.ygyno.2019.03.250\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Download the article<\/strong><\/a><br \/>The publication has been featured in <a href=\"https:\/\/www.thelancet.com\/journals\/lanonc\/article\/PIIS1470-2045(19)30224-4\/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>The Lancet Oncology<\/strong><\/a> and <a href=\"https:\/\/www.medpagetoday.com\/hematologyoncology\/cervicalcancer\/79117\" target=\"_blank\" rel=\"noopener noreferrer\"><strong>Medpage Today<\/strong><\/a><br \/><em>Publication<\/em><\/p>\n\n\n<p class=\"eplus-wrapper wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Diane. M. Harper, et al.Gynecologic Oncology, April 2019 &#8211; Download the articleThe publication has been featured in The Lancet Oncology and Medpage TodayPublication<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uag_custom_page_level_css":"","footnotes":""},"categories":[181,132,5,94],"tags":[],"class_list":["post-39930","post","type-post","status-publish","format-standard","hentry","category-other-fr","category-132","category-publication-fr","category-tg4001-ok","entry"],"uagb_featured_image_src":{"full":false,"thumbnail":false,"medium":false,"medium_large":false,"large":false,"1536x1536":false,"2048x2048":false,"post-thumbnail":false},"uagb_author_info":{"display_name":"alcyon","author_link":"https:\/\/www.transgene.com\/fr\/author\/alcyon\/"},"uagb_comment_info":0,"uagb_excerpt":"Diane. M. Harper, et al.Gynecologic Oncology, April 2019 &#8211; Download the articleThe publication has been featured in The Lancet Oncology and Medpage TodayPublication","_links":{"self":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39930","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/comments?post=39930"}],"version-history":[{"count":2,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39930\/revisions"}],"predecessor-version":[{"id":39936,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/posts\/39930\/revisions\/39936"}],"wp:attachment":[{"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/media?parent=39930"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/categories?post=39930"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.transgene.com\/fr\/wp-json\/wp\/v2\/tags?post=39930"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}